Mounjaro Cost Without Insurance in 2026: Every Option Compared
By Vincent Couey, RxGrab founder. Reviewed by Vincent Wesley Couey. Updated .
Mounjaro is Eli Lilly's tirzepatide for type 2 diabetes, and it is the same molecule as the weight-loss brand Zepbound. That shared molecule is the key to understanding its pricing, because the two brands are sold completely differently. If your insurance does not cover Mounjaro, here is every real way to reduce the cost. For the semaglutide side (Ozempic and Wegovy), see our Ozempic cost breakdown, and for the weight-loss head-to-head, our Zepbound vs Wegovy comparison.
The raw math: at roughly $1,069 per month retail, an uninsured Mounjaro patient spends about $12,000 to $13,000 per year on a single medication. And because it treats a chronic condition, that cost is ongoing. The good news is that several pathways can cut it sharply, but which one applies depends heavily on your insurance status, and that is where the Mounjaro-versus-Zepbound distinction matters most.
Current Mounjaro Retail Prices (2026)
| Source | Monthly Cost | Notes |
|---|---|---|
| Eli Lilly list price | $1,069 | Published 2026 list price |
| Walgreens / CVS retail | $1,050-$1,150 | Cash price, varies by location |
| Costco | ~$1,020 | Often below big-chain retail |
| Walmart | ~$1,000 | Frequently the lowest major-chain cash price |
| GoodRx coupon | $980-$1,050 | Varies by location |
Same pen, five checkout counters
The fact that trips up most Mounjaro shoppers: there is no LillyDirect cash-pay option for Mounjaro, only for Zepbound.THE MOUNJARO CATCH
Option 1: Mounjaro Savings Card ($25/month)
Best price, but only if you have commercial insurance
Eli Lilly's Mounjaro Savings Card can reduce your cost to as little as $25/month. The eligibility rules are strict:
- You must have commercial (private) insurance that covers Mounjaro
- You cannot be on Medicare, Medicaid, or any government insurance
- The card covers the gap between your copay and $25, up to a monthly maximum
Option 2: The Zepbound-vial workaround (same molecule)
This is the option most Mounjaro guides never mention. Mounjaro and Zepbound are the same active ingredient, tirzepatide. Mounjaro carries the type 2 diabetes label; Zepbound carries the weight-management label. Crucially, Eli Lilly sells Zepbound direct to self-pay patients through LillyDirect, but does not offer the same cash-pay program for Mounjaro (confirmed as of 2026).
So if you are paying cash and your prescriber determines Zepbound is clinically appropriate for you, the LillyDirect Zepbound vial is the closest self-pay route to the same molecule:
| LillyDirect Zepbound vial (self-pay) | Monthly Cost |
|---|---|
| 2.5 mg | $299 |
| 5 mg | $399 |
| 7.5 mg to 15 mg | $449 (45-day refill rule applies) |
Option 3: Lilly Cares Patient Assistance (Free)
Lilly Cares provides Mounjaro at no cost to qualifying uninsured patients:
- Must be a U.S. resident
- Uninsured, or without coverage for Mounjaro
- Household income at or below roughly 400% of the federal poverty level
- Application requires income documentation and a prescriber's signature
If approved, you receive Mounjaro directly from the program at no cost. For uninsured patients who qualify, this is the cheapest path of all. Details are in our patient assistance program guide.
Option 4: Compounded tirzepatide (now restricted)
Compounded tirzepatide was widely available while the FDA listed tirzepatide in shortage. After the FDA declared the tirzepatide shortage resolved, mass compounding of tirzepatide was wound down, so it is no longer the reliable low-cost path that compounded semaglutide still is during its own shortage. If a legitimate compounded option applies to your situation, use only 503B-registered pharmacies and confirm current FDA guidance first. Do not rely on "peptide" or "research chemical" websites, which are not pharmacies.
Option 5: Medicare (about $50/month for diabetes)
If you have Medicare and are prescribed Mounjaro for type 2 diabetes, Medicare Part D covers it, and following Inflation Reduction Act price negotiation many Medicare patients pay around $50/month in 2026. Medicare does not cover Mounjaro for weight loss, and Medicare patients cannot use the commercial $25 savings card.
Option 6: Therapeutic alternatives (for diabetes)
If you take Mounjaro for type 2 diabetes and cost is prohibitive, ask your doctor whether a cheaper drug fits your case:
| Alternative | Monthly Cost | Type | Notes |
|---|---|---|---|
| Metformin | $4 | Generic | First-line diabetes drug, Walmart $4 |
| Glipizide | $4 | Generic | Sulfonylurea, Walmart $4 |
| Ozempic (semaglutide) | $349 direct | Brand GLP-1 | Available direct via TrumpRx/NovoCare |
| Jardiance | $50-$100 | Brand | SGLT2 inhibitor |
Note the contrast: Ozempic, the semaglutide GLP-1, is available direct to self-pay patients at about $349/month, while Mounjaro is not, so for a cash-paying diabetes patient who needs a brand GLP-1, the semaglutide route can be cheaper to access than brand Mounjaro. See the Ozempic cost guide for that path. Always let your doctor decide what is clinically right for you.
How to find your cheapest Mounjaro price: a decision tree
- Do you have commercial insurance that covers Mounjaro? Use the Mounjaro Savings Card. Your cost: $25/month.
- Do you have Medicare with type 2 diabetes? Part D covers it at about $50/month. You cannot use the $25 card.
- Are you uninsured with income at or below ~400% FPL? Apply to Lilly Cares. Your cost: $0 if approved.
- Are you uninsured, above that income line, and paying cash? Mounjaro has no direct cash-pay option, so ask your prescriber whether the LillyDirect Zepbound vial ($299 to $449, same molecule) fits your case.
- Is cost still the barrier and you have diabetes? Ask about $4 generics like metformin, or the direct-pay Ozempic route at $349.
Price Comparison Summary
| Option | Monthly Cost | Who Qualifies |
|---|---|---|
| Lilly Cares Patient Assistance | $0 | Low-income, uninsured |
| Mounjaro Savings Card | $25 | Commercially insured (plan covers Mounjaro) |
| Medicare Part D (diabetes) | ~$50 | Medicare enrollees with type 2 diabetes |
| Zepbound vial workaround (same molecule) | $299-$449 | Cash-pay, if prescriber agrees Zepbound fits |
| Retail cash price | $1,000-$1,150 | Anyone |
Frequently Asked Questions
Is there a LillyDirect cash-pay option for Mounjaro?
No. As of 2026 Eli Lilly does not sell Mounjaro through a LillyDirect direct-to-patient cash-pay program. That option exists only for Zepbound, which contains the same active ingredient, tirzepatide, but carries the weight-management label. Uninsured patients cannot buy brand Mounjaro direct the way they can buy Zepbound vials for $299 to $449 a month. If your prescriber determines Zepbound is appropriate, the Zepbound vial is the closest self-pay path to the same molecule.
How much does Mounjaro cost without insurance in 2026?
About $1,069 a month at retail, matching Eli Lilly's 2026 list price, with pharmacy cash prices commonly ranging from roughly $1,000 to $1,200 for a 28-day supply of four auto-injector pens. Walmart is frequently the lowest major-chain cash price at around $1,000. That is roughly $12,000 to $13,000 a year out of pocket without a savings program.
How can I get Mounjaro for $25 a month?
The Mounjaro Savings Card can bring your cost to as little as $25 a month, but only if you have commercial insurance that covers Mounjaro. It does not apply to uninsured patients or to anyone on Medicare or Medicaid. If your commercial plan covers Mounjaro, the savings card is by far the cheapest path; if you are uninsured, look at Lilly Cares patient assistance or the Zepbound-vial route instead.
Does Medicare cover Mounjaro?
Yes, for type 2 diabetes. Medicare Part D covers Mounjaro when prescribed for diabetes, and following Inflation Reduction Act price negotiation many Medicare patients pay around $50 a month in 2026. Medicare does not cover Mounjaro for weight loss, and Medicare patients cannot use the commercial $25 savings card.
Is compounded tirzepatide still available for Mounjaro?
Largely no. Compounded tirzepatide was widely available while the FDA listed tirzepatide in shortage, but after the FDA declared the tirzepatide shortage resolved, mass compounding of tirzepatide was wound down and is no longer a reliable path the way compounded semaglutide still is during its shortage. Always check current FDA guidance and use only 503B-registered pharmacies if a legitimate compounded option applies.
Key Takeaways
- Mounjaro retails for about $1,069/month without insurance -- roughly $12,000 to $13,000/year.
- Unlike Zepbound, Mounjaro has no LillyDirect cash-pay option, so uninsured patients cannot buy it direct.
- The $25 savings card works only with commercial insurance that covers Mounjaro.
- Uninsured cash-pay patients' closest route to the same molecule is the LillyDirect Zepbound vial ($299-$449), only if a prescriber agrees it fits.
- Low-income uninsured patients can get Mounjaro free through Lilly Cares; Medicare diabetes patients pay about $50.
Get Mounjaro price alerts
We track pricing changes, new savings programs, and direct-pay updates for tirzepatide.